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Background: Suppression of cyclic activity in cattle is often desired in alpine farming and for feedlot cattle, not
intended for breeding. A cattle specific anti-GnRF vaccine (Bopriva™) is registered for use in heifers and bulls in
different countries. In adult cows vaccinated with Bopriva™, the median period until recurrence of class III follicles
was 78 days from the day of the 2nd vaccination and reversibility could be proven, as out of 11 experimental cows
10 cows became pregnant at first, and one cow at second insemination. In the present study, 76 healthy, cyclic
Eringer heifers and cows were vaccinated twice with Bopriva™ 3-7 weeks apart, to prevent estrus during alpine
pasturing. Blood samples were taken for progesterone and GnRF antibody titer analysis on the day of inclusion (7–9
d before the first vaccination) and at the first vaccination. At the same time, gynaecological examinations were
performed. When estrus occurred in the course of the alpine pasturing season, a gynaecological examination was
done including analysis of a blood sample (progesterone, anti-GnRF antibody titer). Cows were followed for fertility
out to 26 months post second vaccination.
Results: Median duration of estrus suppression was 191 days after the second vaccination (when the 2 vaccinations
were given 28–35 days apart). From n = 13 cows showing signs of estrus on the alpine pasture, n = 7 could not be
confirmed in estrus (serum progesterone value >2 ng/ml, no class III follicles seen using ultrasonography). Median
duration between second vaccination and next calving was 496 days (25%/75% quartiles: 478/532 days).
Conclusion: Bopriva™ induced a reliable and reversible suppression of estrus for more than 3 months in over 90%
of the cows.
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Estrus suppression is desired by cattle owners for feedlot
animals not intended for breeding and for animals in sea-
sonal breeding management (e.g. summer pasturing in the
Alps). Young heifers and older beef cows are often uninten-
tionally pregnant at slaughter (Federal Food Safety and Vet-
erinary Office: Projekt Schlachtung von trächtigen Rindern
– Prävalenz und Gründe der Schlachtung). Immunization
against GnRF has been used to reduce sexual behavior and
to prevent the development of secondary sexual character-
istics in males [1–8], and for suppression of estrous cycles
[9] and prevention of unwanted pregnancies in females [10,
11]. GnRF antibody titers, ovarian function, progesterone* Correspondence: gaby.hirsbrunner@vetsuisse.unibe.ch
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tween immunized and non-immunized heifers [9]. In adult
cows vaccinated with Bopriva™ (Zoetis Australia Limited,
38–42 Wharf Road, West Ryde, NSW 2114, Australia), the
median period until recurrence of class III follicles (> 9 mm
in diameter and less than 2 cm; [12]) was 78 days from the
day of the 2nd vaccination [13]. It was also shown that the
absence of class III follicles was the best clinical indicator of
anestrus.
Estrous behavior of the cows, though, was inhibited
for 30 weeks (180 days after second vaccination). Revers-
ibility could be proven, as 10 out of 11 cows fell preg-
nant soon after first, and 1 cow after the second
insemination [13]. In pastures with commingling of cows
from different farms of origin, non-pregnant cows may
cause agitation and accidents in the herd because of re-
curring estrous behavior. This is especially accentuatedle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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lected for dominance abilities [14]. Estrus suppression
during pasture commingling is highly valued, but cur-
rently, with the exception of intravaginal progesterone
devices, no pharmaceuticals are approved in Switzerland
for suppression of cycling activity in food-producing ani-
mals. Immunization against GnRF is a likely animal-
friendly alternative. Therefore, the aim of this prospect-
ive study was to evaluate the duration and efficiency of
an active immunization against GnRF using Bopriva™ for
estrus suppression in free range adult Eringer cattle dur-
ing mountain pasturing in the Swiss Alps. Their fertility
variables in the subsequent breeding season were de-
scribed. We hypothesized that the vaccination induced
estrus suppression would last longer than 80 days after
the 2nd vaccination and that it would be reversible.
Methods
Animals, inclusion and exclusion criteria
From April to May 2014, n = 76 heifers and cows of the
Eringer breed (confirmed non-pregnant) spending the
summer free ranging on the Alps with daily supervision
were included in the study. Animals suffering from puru-
lent vaginal discharge, inseminated less than 30 days be-
fore and with a history of recurring ovarian cysts were
excluded from the study. The history of the cows and the
structure of the farms were investigated by a questionnaire
for the owners. Calving dates and number of insemina-
tions in the preceding and subsequent season were add-
itionally sourced from the Swiss animal movement data
base (www.agate.ch) and the Eringer breeding association.
Gynaecological examination
The cows were examined twice (at inclusion and first
vaccination) within 7–9 days including a vaginoscopy, a
rectal palpation of the genital tract and an ultrasonogra-
phical examination. Uterine symmetry and tone, cervical
opening and properties, and amount of vaginal discharge
were recorded [15]. Using ultrasonography (Magic 500,
Eickemeyer, Eickemeyer Medizintechnik, Appenzell,
Schweiz), the number of follicles was recorded and
assigned to 1 of 3 categories, according to the classifica-
tion of Moreira et al. [16]: class I follicles (≤5 mm in
diameter), class II follicles (6–9 mm in diameter), and
class III follicles (>9 mm and <2 cm in diameter) [12].
The presence of a corpus luteum (CL) was also noted.
Blood sampling, GnRF antibody titer and progesterone
In all animals, blood was sampled at inclusion, at first
and second vaccination and at the time of the first heat
after estrus suppression. The blood samples were col-
lected by venipuncture from the coccygeal vein into hep-
arinized tubes, centrifuged (4000 x g, 10 min), and
plasma was then stored at −18 °C for later analysis.GnRF antibody titers were determined by dissociation
enhanced lanthanide fluorescence immunoassay (DELFIA)
(PerkinElmer Pty Ltd., Glen Waverly, Australia), and re-
sults were expressed as relative light units (RLU). Briefly,
384-well streptavidin coated plates (PerkinElmer Pty Ltd.,
Glen Waverly, Australia) were coated for 1 h at room
temperature with 1 μg/mL biotinylated modified GnRH
peptide in DELFIA buffer (50 mM Tris-HCl, 0.9% NaCl,
0.05% Tween 20, 20 μM EDTA, 0.2% ovalbumin). Plates
were washed and then incubated for 1 h at RT with 50 μL
aliquots of cattle samples serially diluted to 1/800 in DEL-
FIA buffer. Unbound plasma and antibodies were re-
moved by washing, and bound antibody was detected by
incubating plates for a further 1 h with 50 μL of europium
labeled protein G (PerkinElmer Pty Ltd., Glen Waverly,
Australia). After washing off excess europium labeled pro-
tein G, DELFIA Enhancement Solution (PerkinElmer Pty
Ltd., Glen Waverly, Australia) was added to all wells to
dissociate bound lanthanide from the antigen forming a
highly fluorescent chelate. After 10 min, the intensity of
fluorescence was measured by excitation at 340 nm and
emission readings at 615 nm using a time resolved
fluorometer (Envision 2102 Multireader, Perkin Elmer).
Pooled non-vaccinated cattle samples served as a negative
control. Unknown samples were compared to serial dilu-
tions of a standard positive reference immune cattle sam-
ple. Calculation of a standard curve and reading of
unknown samples were performed using the WorkOut 2.5
software (Dazdaq Solutions Ltd., East Sussex, England).
Intra- and inter-assay CV were 6.7% and 8.5%, respect-
ively. Serology titers showed a 120 fold range from 3850
RLU titers units for negative samples to 495,000 titers
units for immune samples, with 11,500 RLU being taken
as the lower cut-off differentiating positive from negative
samples. Lowest detection level of GnRF antibody titer
was 3850 units [13].
Progesterone concentration was measured using radio-
immunoassay (Immunotech, Beckman Coulter, Sin-
sheim, Germany). The intra-assay coefficient of variation
(CV)% was 5.3% and the inter-assay CV% 7.7% deter-
mined by using a bovine pool serum, measured 30 times
within a test routine and between 25 assay runs. The
analytical sensitivity was 0.05 ng/mL and the measure-
ment range was 0.05–50 ng/mL. The assay was per-
formed according to the manufacturer’s instructions.
Treatment; GnRF vaccine
The treatment consisted of two vaccinations with the anti-
GnRF vaccine Bopriva™ (Bopriva, Zoetis Australia Limited,
38–42 Wharf Road, West Ryde, NSW 2114, Australia)
4 weeks apart whenever applicable. Bopriva™ contains an
analogue of GnRF linked to a carrier protein accompanied
by a synthetic aqueous adjuvant (400 μg GnRF-protein-
conjugate per mL) and is registered with claims to
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as well as to suppress estrous behavior in post-pubertal
heifers. The dosage used for both the initial and the
booster vaccination was 400 μg GnRF-protein-conjugate
(1 mL Bopriva™). All injections were administered sub-
cutaneously on the right side of the neck.
All animal experimentation was performed with per-
mission and in accordance to Swiss law (https://
www.blv.admin.ch/blv/en/home/tiere/tierversuche.html;
Nr. G54/3616).
Clinical evaluation, side effects
Behaviour and food intake was carefully observed by the
owners. If activity and / or food intake was judged to be
reduced for more than 25%, a veterinarian was con-
sulted. The injection site was palpated for signs of heat,
swelling and sensitivity daily for 1 week. Estrous behav-
ior observation was conducted daily during alpine pas-
turing by the responsible herdsmen.
Follow-up
Owners were instructed to immediately report if animals
showed estrous behavior. When estrous behavior was
observed, a gynaecological examination was performed
and another blood sample was taken for analysis of
GnRF-antibody titer and serum progesterone concentra-
tion. In the cows’ first heat after the alpine season, blood
samples were planned to be taken and examined.
All owners completed a second questionnaire concern-
ing the first heat of the cows, number of inseminations
until next pregnancy and reasons for leaving the farm.
Data of subsequent calving was taken from the Swiss ani-
mal transportation internet portal (www.agate.ch).
Statistical analysis
The continuous variables are described as mean, sd, me-
dian and quartiles, the categorical with absolute and
relative frequencies. The primary endpoint “period from
2nd vaccination to estrus” was analyzed with the non-
parametric Kaplan-Meier survival function, since some
of the cows were slaughtered before coming in heat
which is considered as censored time periods. The dif-
ferent periods of the different groups were compared
with the log rank test. Several explanatory factors were
investigated with the Cox regression. A p-value <0.05 in-
dicated a significant result.
Results
Animals, inclusion and exclusion criteria
Ten cows and heifers were excluded because of a missing
second vaccination, culling due to other reasons than fertil-
ity problems during the alpine pasturing season. Seventy-
six animals (13 heifers and 63 cows) were included. Before
the alpine pasturing season 90% of the owners took care oftheir animals themselves, whereas 10% of the owners used
a communal cattle shed. All owners preferred seasonal calv-
ing from September to December. Concerning the use of
the cows, 58.3% of the owners indicated to milk them for a
mean of 180 days, 37.5% used them as beef (suckling) cows
for a mean of 120 days, and 4.2% of the owners neither
milked them nor let the calf suckle. Mean herd size was 10
cows and 4 heifers, 96% of these animals spent the summer
on the Alps.
Cows’ histories
Median age of the cows and heifers was 5.3 yr. (range:
1.8–10.9 yr). First calving age of the cows was 3.1 yr.
(median; range 1.8–4.8 yr). Preceding intercalving period
was 445.9 days (mean; range: 311–779 days). Conception
index for the preceding pregnancy was 1.5 (median),
conception rate at first insemination was 50% and at sec-
ond insemination was 51.7%. Signs of heat were consid-
ered “good” in 67.6%, “moderate” in 26.5% and “not
observed” in 5.9% according to the owner’s judgment.
Culling rate due to fertility problems was 9.4%.
Gynaecological examination at inclusion / first
vaccination
On the day of inclusion, 10 animals suffered from an urova-
gina. At the time of inclusion and time of first vaccination
67 and 70 animals, respectively had a small uterus that was
retractable onto the floor of the pelvis. None of the animals
had proliferations of the most caudal cervical ring. A func-
tional CL was present in 46 and 47 of cattle at the time of
inclusion and the time of the first vaccination, respectively.
Median number of class I-II-III follicles was 2–1-0 at inclu-
sion and 2–1-1 at first vaccination (Additional file 1).
GnRF vaccine; side effects
The 2 vaccinations were performed 20–49 days apart
(median 32 days). None of the owners identified any ser-
ious adverse side effects in their cows. Most of the cows
treated with Bopriva™ showed a slight swelling at the in-
jection site, varying in severity, and moderate local pain
for 2–9 days after vaccinations.
GnRF antibody titer and progesterone
The GnRF antibody titer at the inclusion of the study
and on the day of the first vaccination was below the de-
tection limit (3800 units). At the second vaccination, the
titers ranged between 3850 and 236,998 units (median:
17,870 units) in 62 cows, while in 12 cows, the titer was
still below the detection limit (2 results missing). Median
titers in heifers at second vaccination and at first signs
of heat were higher compared to median values in cows
(Table 1). Median antibody titer of animals seen with
signs of heat was 3850 (range 3850–16,623).
Table 1 Anti-GnRF antibody titer (DELFIA) in heifers and
pluriparous cows at first and second vaccination and at




25% quartile 3.850 3850
75% quartile 3850 3850
Second vaccination
Median 28,919 15,520
25% quartile 19,501 10,939
75% quartile 41,899 22,494




First signs of estrus after the alpine season
Median 17,772 3850
25% quartile 13,885 3850
75% quartile 35,420 10,775
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ml (median: 4.7 ng/ml) at first examination. At first vac-
cination, the serum progesterone levels ranged from
0.3–40 ng/ml (median: 6 ng/ml), with 15 cows ≤2 ng/ml.
At the second vaccination, the serum progesterone levels
ranged from 0.2–32.1 ng/ml (median: 2.8 ng/ml) with 33
cows ≤2 ng/ml.Vaccination induced anestrus
One heifer and twelve cows showed signs of estrus
while on pasture and 30 animals were detected after
return to the farm of origin (alpine season 100–
150 days depending on climate). Median duration of
estrus suppression after the second vaccination was
113 days (<28 days between the 2 vaccinations),
191 days (28–35 days between the 2 vaccinations)
and 229 days (>35 days between the 2 vaccinations).
The cox regression was started with the period “2nd
vaccination to heat” in days and the explanatory fac-
tors “cow”, “serum progesterone value at 1st and 2nd
vaccination” and the categorized variable “period be-
tween the 2 vaccinations”. The latter was grouped in
group 1 (< 28 days), group 2 (28–35 days), and group
3 (> 35 days). The backward selection revealed only
group 1 as a significant factor with p < 0.0001. Figure
1 shows the percentages of days between the second
vaccination and heat in the three groups. Plasma pro-
gesterone at the time of the first and second vaccin-
ation did not affect duration of estrus suppression.Follow-up
Follow-up data were included until 26 months after the sec-
ond vaccination. Out of the 76 cows, 35 cows were culled
within a median of 134 days after the second vaccination.
From these 35 cows, 23 were culled without being insemi-
nated (planned to be culled after alpine pasturing), 7 were
culled for fertility reasons and 5 for reasons other than fer-
tility problems. Median duration between second vaccin-
ation and subsequent calving in 37 cows was 496 d. Calving
data of four cows was not available, but they were pregnant
in the 2015/2016 season.
Discussion
Our hypothesis was confirmed: the cows’ estrus was sup-
pressed for more than 80 d. The alpine pasturing season
lasts for a minimum of 100 d, depending on the weather.
Therefore, the length of cycle suppression for cows vacci-
nated with Bopriva™ was satisfactory, and depended on the
length of the period between the 2 vaccinations (medians
ranged from 113 to 229 days). To our knowledge, this vari-
ability in response in females has not been described yet,
whereas in bulls it is known, that the duration of testoster-
one suppression is dependent on the type of adjuvant used,
and the number of and the interval between the vaccina-
tions (3–4 weeks versus 6–8 weeks) [17]. GnRF antibody ti-
ters at second vaccination and at first signs of heat were
increased in heifers as compared to pluriparous cows. As
only 17% of the animals included were heifers, a statistical
difference could not be determined between the 2 groups.
Only twelve cows and one heifer were observed with signs
of estrus during alpine pasturing. However, seven of these
animals had serum progesterone values >2 ng/ml, no class
III follicles when examined on the alpine pasture, but me-
dian antibody titers were below the detection limit. In
mares vaccinated against GnRF, estrous behavior occurred
in anovulatory mares, as only small amounts of estradiol
are needed for induction of estrous signs [18]. The charac-
teristics of the old breed “Eringer” are known to be domin-
ant and hot-tempered [14] and might be intensified in the
alpine pasturing systems. In older bulls “learnt behaviors”
may contribute to sexual behaviors that persist following
vaccination with Bopriva™ (personal communication Sue
Amatayakul-Chantler). It is possible that the behavioral
signs of estrus in cattle may not always be related to find-
ings on the ovaries and serum progesterone concentrations.
The GnRF antibody titer increases 2–3 weeks after the
first vaccination and peaks 2 weeks after the second vaccin-
ation. Due to alpine pasturing logistics, it was not feasible
to measure the anti GnRF antibody titer during the alpine
season, except for those cows observed in heat in which
serum samples could be taken on the Alps. Median dur-
ation between second vaccination and subsequent calving
was 496 days. This period consists of 280 days pregnancy
and 150 days of alpine pasturing and a voluntary waiting
Fig. 1 Kaplan Meyer graph representing the percentage of cattle within group 1–3, versus the duration of the period between second
vaccination and estrus. The median times are 113, 191 and 229 days in the three groups. Group 1 (blue) = < 28 days, group 2 (brown) = 28–
35 days, and group 3 (green) = > 35 days between the vaccinations. † mean censored data
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rules demand a seasonal calving, with 80% of the calvings
occuring between October and December [19]. The calving
month and seasonal calving were the most important rea-
sons for a prolonged calving to conception interval in this
breed [19]. Therefore, the evaluation of classic fertility vari-
ables is difficult in the Eringer cows and vaccinated with
Bopriva™, as their preceding calving was between October
2012 and March 2014. Owners prefer to let the cows open
instead of allowing them to calve during the wrong season
of the year.
Unfortunately, 29% (23/76) of the cows were culled
within 6 months after the alpine season e.g. before the end
of the subsequent breeding season. For the owners of
those cows, it was important that the estrous cycle of the
cows be suppressed during the alpine season, so cows
could be slaughtered in the fall or winter, when meat
prices are higher. In the remaining cows, the culling rate
due to fertility problems was 9.2% similar to 9.4% from
the preceding season. Our results support those from a
previous study that Bopriva™ does not negatively impact
bovine fertility [13].
Conclusion
We can highly recommend anti-GnRF vaccination
(Bopriva™) for reversible suppression of estrus in Eringer
cattle spending the summer on alpine pasture. For a
period of 28–35 days between the two vaccinations anes-
trus is lasting up to 216 days with a median of 191 days.
If a longer period of cycle suppression is desired, the
period between the two vaccinations should be >35 days.Seventy percent of the cows calved in the subsequent
calving seasons.
Additional file
Additional file 1: Data of all cows included. Gynaecological examinations,
dates of vaccinations, titers (anti-GnRF and progesterone at inclusion, at first
vaccination, at 2nd vaccination, at first heat). (XLSX 51 kb)
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